67 related articles for article (PubMed ID: 19151561)
21. Developing biomarker-specific end points in lung cancer clinical trials.
Neal JW; Gainor JF; Shaw AT
Nat Rev Clin Oncol; 2015 Mar; 12(3):135-46. PubMed ID: 25533947
[TBL] [Abstract][Full Text] [Related]
22. [Target therapy in lung cancer].
Rowińska-Zakrzewska E; Szturmowicz M
Pneumonol Alergol Pol; 2004; 72(9-10):453-9. PubMed ID: 16022004
[No Abstract] [Full Text] [Related]
23. Long-term survival in patients with inoperable and metastasized cancer.
Seeber S
Onkologie; 2008 Sep; 31(8-9):427-8. PubMed ID: 18787347
[No Abstract] [Full Text] [Related]
24. [Tumor markers and lung cancer. What's new?].
Sánchez de Cos Escuín J; Hernández Hernández J
Arch Bronconeumol; 2004 Dec; 40 Suppl 6():35-40. PubMed ID: 16137465
[No Abstract] [Full Text] [Related]
25. [The role of bacterial flora on the diagnosis and treatment efficacy in patients with lung cancer].
Zhao Z; Bai H; Fei KL; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jul; 43(7):585-588. PubMed ID: 32629559
[TBL] [Abstract][Full Text] [Related]
26. [Advances in bronchial cancer].
Depierre A
Presse Med; 2002 May; 31(17):795-6. PubMed ID: 12148363
[No Abstract] [Full Text] [Related]
27. Inhaled insulin for the early detection of lung cancer.
Lehrer S
Med Hypotheses; 2008 Oct; 71(4):615-6. PubMed ID: 18602221
[No Abstract] [Full Text] [Related]
28. Lipid metabolism and lung cancer.
Merino Salvador M; Gómez de Cedrón M; Moreno Rubio J; Falagán Martínez S; Sánchez Martínez R; Casado E; Ramírez de Molina A; Sereno M
Crit Rev Oncol Hematol; 2017 Apr; 112():31-40. PubMed ID: 28325263
[TBL] [Abstract][Full Text] [Related]
29. Early detection of cancer of the lung.
PAULSON DL
Ill Med J; 1960 Dec; 118():348-50. PubMed ID: 13733505
[No Abstract] [Full Text] [Related]
30. Screening and early diagnosis in lung cancer.
Postmus PE
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1529-31. PubMed ID: 18925844
[No Abstract] [Full Text] [Related]
31. Commentary: early diagnosis of lung cancer: where do we stand?
Paleari L; Granone P; Grozio A; Cesario A; Russo P
Oncologist; 2007 Dec; 12(12):1433-6. PubMed ID: 18165620
[No Abstract] [Full Text] [Related]
32. TREATMENT OF LUNG CANCER.
MCCALLUM AH
Br Med J; 1965 Sep; 2(5462):604-5. PubMed ID: 14331616
[No Abstract] [Full Text] [Related]
33. Michigan's 3000 candidates for practical cancer.
BRENNAN MJ
J Mich State Med Soc; 1963 Apr; 62():398-400. PubMed ID: 14015235
[No Abstract] [Full Text] [Related]
34. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.
John T; Liu G; Tsao MS
Oncogene; 2009 Aug; 28 Suppl 1():S14-23. PubMed ID: 19680292
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers for lung cancer: clinical uses.
Greenberg AK; Lee MS
Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor as a target in cancer therapy.
Kim ES
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S87-95. PubMed ID: 19795581
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
Modjtahedi H; Essapen S
Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
[TBL] [Abstract][Full Text] [Related]
38. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
39. [Lung cancer].
Ayabe E; Kaira K; Yamamoto N
Gan To Kagaku Ryoho; 2009 Jan; 36(1):21-5. PubMed ID: 19151561
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
